Skip to main content

Table 1 Patient characteristics of patient Cohort I, II and III

From: Definition by FSH, AMH and embryo numbers of good-, intermediate- and poor-prognosis patients suggests previously unknown IVF outcome-determining factor associated with AMH

  Cohort I Cohort II Cohort III
Cycles (n) 1247 1514 632
Embryos (n) 4.9 ± 4.3 4.0 ± 3.4 4.1 ± 3.5
Age (years) 37.8 ± 6.7 39.5 ± 5.0 39.5 ± 4.9
FSH (mIU/mL) 17.3 ± 19.1 15.4 ± 14.8 15.8 ± 16.2
AMH (ng/mL) 1.1 ± 1.9 1.1 ± 1.9 1.1 ± 1.9
Pregnancies
 n 346 246 106
 % 27.8 16.2 16.8
Live births
 n 264 178 73
 % 21.2 11.8 11.6
Miscarriages
 n 82 68 33
 % 23.7 27.6 31.3